Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 169.19M
March 31, 2026 161.23M
December 31, 2025 139.48M
September 30, 2025 139.02M
June 30, 2025 138.89M
March 31, 2025 138.06M
December 31, 2024 136.96M
September 30, 2024 136.71M
June 30, 2024 136.59M
March 31, 2024 135.84M
December 31, 2023 134.78M
September 30, 2023 134.50M
June 30, 2023 134.23M
March 31, 2023 133.93M
December 31, 2022 133.24M
September 30, 2022 133.03M
Date Value
June 30, 2022 132.60M
March 31, 2022 132.35M
December 31, 2021 131.16M
September 30, 2021 130.83M
June 30, 2021 130.48M
March 31, 2021 129.89M
December 31, 2020 127.42M
September 30, 2020 126.99M
June 30, 2020 117.73M
March 31, 2020 108.35M
December 31, 2019 107.65M
September 30, 2019 109.68M
June 30, 2019 109.68M
March 31, 2019 109.68M
December 31, 2018 110.47M
September 30, 2018 109.68M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Moderna, Inc. 399.00M
Vaxcyte, Inc. 144.79M
Caribou Biosciences, Inc. 106.00M
Arrowhead Pharmaceuticals, Inc. 141.14M
Oncolytics Biotech, Inc. 124.64M